Role of sodium in hemodialysis

被引:95
作者
Flanigan, MJ [1 ]
机构
[1] Univ Iowa Hosp & Clin, Dept Med, Iowa City, IA 52242 USA
关键词
salt; plasma osmolality; cell volume; intracellular tonicity; dialysate; renal replacement therapy;
D O I
10.1046/j.1523-1755.2000.07609.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Sodium chloride is the most abundant salt in extracellular fluid. In normal individuals, the tonicity exerted by disserved sodium chloride determines plasma osmotality and indirectly determines intracellular tonicity and eel volume. Uremic patients retain nitrogenous wastes and have an elevated plasma osmolality. While urea exhibits osmotic activity in serum, no sustained gradient can be established across cell boundaries because it readily diffuses through cell membranes. Thus, sodium remains the major indicator of body tonicity and determines the distribution of water across the intracellular-extracellular boundary. subsequent cell volume, thirst, and, among patients with renal insufficiency, systemic blood pressure. As a result of highly conserved plasma tonicity control systems, uremic subjects demonstrate remarkable stability of their serum sodium Dialysate is a synthetic interstitial fluid capable of reconstituting extracellular fluid composition through urea extraction and extremely efficient solute and solvent (salt and water) transfer to the patient. Subtle transdialyzer gradients deliver and remove large quantities of trace elements, solvent, and solute to patients, creating a variety of dialysis "disequilibrium" syndromes manifest as cellular and systemic distress. Every dialysis patient uses dialysate, and the most abundant chemicals in dialysate are salt and water. Despite its universal use, no consensus on dialysate composition or tonicity exists. This can only be explained if we believe that dialysate composition is best determined by matching unique dialysis delivery system characteristics to specific patient requirements. Such a paradigm treats dialysate as a drug and the dialysis system as a delivery device. Understanding the therapeutic and toxic profiles of this drug (dialysate) and its delivery device (the dialyzer) is important to safe, effective, goal-directed modifications of therapy. This article explores some of the historical rationale behind choosing specific dialysate tonicities.
引用
收藏
页码:S72 / S78
页数:7
相关论文
共 58 条
  • [1] EFFECT OF DIALYSIS AND RENAL-TRANSPLANTATION ON AUTONOMIC DYSFUNCTION IN CHRONIC-RENAL-FAILURE
    AGARWAL, A
    ANAND, IS
    SAKHUJA, V
    CHUGH, KS
    [J]. KIDNEY INTERNATIONAL, 1991, 40 (03) : 489 - 495
  • [2] ARIEFF AI, 1976, CLIN ASPECTS UREMIA, P34
  • [3] BARBOUR BH, 1976, CLIN ASPECTS UREMIA, P659
  • [4] BONBRECHT JH, 1985, DIALYSIS TRANSPLANT, V14, P75
  • [5] TOTAL-BODY ELECTROLYTE-COMPOSITION AND DISTRIBUTION OF BODY-WATER IN UREMIA
    BRENNAN, BL
    YASUMURA, S
    LETTERI, JM
    COHN, SH
    [J]. KIDNEY INTERNATIONAL, 1980, 17 (03) : 364 - 371
  • [6] CHRISTIAN GD, 1977, ANAL CHEM, P362
  • [7] Clinical use of profiled hemodialysis
    Coli, L
    Bonomini, M
    La Manna, G
    Dalmastri, V
    Ursino, M
    Ivanovich, P
    Bonomini, V
    [J]. ARTIFICIAL ORGANS, 1998, 22 (09) : 724 - 730
  • [8] SYMPATHETIC OVERACTIVITY IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    CONVERSE, RL
    JACOBSEN, TN
    TOTO, RD
    JOST, CMT
    COSENTINO, F
    FOUADTARAZI, F
    VICTOR, RG
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (27) : 1912 - 1918
  • [9] EFFECTS OF HIGH SODIUM DIALYSATE DURING MAINTENANCE HEMODIALYSIS
    CYBULSKY, AVE
    MATNI, A
    HOLLOMBY, DJ
    [J]. NEPHRON, 1985, 41 (01): : 57 - 61
  • [10] ACETATE DIALYSATE VERSUS BICARBONATE DIALYSATE - A CONTINUING CONTROVERSY
    DIAMOND, SM
    HENRICH, WL
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1987, 9 (01) : 3 - 11